Achieving good outcomes for patients with diabetes and cardiovascular disease requires a concerted effort to manage and monitor diabetes and associated comorbidities.

Programmed shared medical appointments are effective, well accepted and cost efficient for body weight management.

Sodium–glucose co-transporter-2 inhibitors are becoming a cornerstone of therapy for type 2 diabetes, kidney disease and heart failure.

Nocturia is associated with significant morbidity and is likely to be a marker of poor health.

Managing cardiovascular risk factors is crucial for improving the overall survival of patients and the outcomes of future abdominal aortic aneurysm repair.

Medicare Benefits Schedule rules regarding sleep study eligibility have recently changed and incorporate validated questionnaires of obstructive sleep apnoea risk and subjective sleepiness.

Although COVID-19 primarily affects the respiratory system, cardiovascular involvement is common, especially in individuals who are severely ill.

Diagnosis of PCOS in an Aboriginal primary care setting is being performed correctly and at a young age; however, subsequent screening of cardiometabolic risk and emotional wellbeing needs more work.